New imaging tools help cancer researchers see inside living cells
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-May-2026 01:15 ET (25-May-2026 05:15 GMT/UTC)
Recent advances in high-throughput proteomics enable the measurement of thousands of proteins simultaneously, offering unprecedented insight into human health and disease. A new review summarizes how proteomic technologies, combined with artificial intelligence, are transforming biomarker discovery, disease prediction, and drug development, highlighting their growing role in advancing precision medicine.
A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent. Findings on the new test, developed by a team from the Perelman School of Medicine at the University of Pennsylvania, are published today in Nature Medicine.
Peer-reviewed study confirming strong predictive performance of patient-specific lung digital twins, validated against clinical imaging data
Whole-lung, physics-based modeling enables locally resolved prediction of drug deposition, addressing a central challenge in inhaled drug development
Validated lung digital twin technology forms the foundation of Ebenbuild’s platform applications, supporting translational research today and regulated clinical use in the future
Every thought, memory, and feeling we experience depends on trillions of tiny connection points in the brain called synapses. These are the junctions where one neuron passes signals to another, forming the vast communication network known as the connectome—the brain’s wiring diagram. Although scientists have developed powerful tools to increase or decrease neural activity, directly redesigning the brain’s physical wiring has remained far more difficult.
A research team led by Dr. LEE Sangkyu and Director C. Justin LEE at the Center for Memory and Glioscience within the Institute for Basic Science (IBS), in collaboration with Dr. LEE Kea Joo of the Korea Brain Research Institute (KBRI), has now developed a molecular tool that makes such structural editing possible. The new platform, called SynTrogo (Synthetic Trogocytosis), enables researchers to induce astrocytes to selectively remodel synaptic connections in a targeted brain circuit.An international group have discovered associations between pathogenic variants of the BRCA 1 and 2 genes and four types of cancer. Published in ESMO Open, the findings expand the potential for personalized medicine to several cancer types that currently have limited treatment options and poor prognoses.